Universal Ibogaine Inc. (TSXV:IBO)
Canada · Delayed Price · Currency is CAD 0.0150
-0.0050 (-25.00%)
Aug 22, 2025, 12:21 PM EDT
Universal Ibogaine Revenue
Universal Ibogaine had revenue of 700.92K CAD in the quarter ending April 30, 2025, with 30.61% growth. This brings the company's revenue in the last twelve months to 2.06M, down -11.68% year-over-year. In the fiscal year ending July 31, 2024, Universal Ibogaine had annual revenue of 2.33M with 126.32% growth.
Revenue (ttm)
2.06M
Revenue Growth
-11.68%
P/S Ratio
2.28
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2024 | 2.33M | 1.30M | 126.32% |
| Jul 31, 2023 | 1.03M | -40.82K | -3.81% |
| Jul 31, 2022 | 1.07M | - | - |
| Jul 31, 2021 | - | - | - |
| Jul 31, 2020 | - | - | - |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.75B |
| Green Thumb Industries | 1.57B |
| Trulieve Cannabis | 1.62B |
| Sienna Senior Living | 929.68M |
| dentalcorp Holdings | 1.62B |
| Cronos Group | 177.69M |
| WELL Health Technologies | 1.12B |
| Extendicare | 1.51B |